Kopp Family Office’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-136,895
| Closed | -$15.6M | – | 23 |
|
|
2022
Q4 | $15.6M | Sell |
136,895
-405,648
| -75% | -$46.2M | 9.38% | 4 |
|
|
2022
Q3 | $33.6M | Sell |
542,543
-1,500
| -0.3% | -$92.8K | 27.33% | 1 |
|
|
2022
Q2 | $43.4M | Sell |
544,043
-792
| -0.1% | -$63.2K | 30.48% | 1 |
|
|
2022
Q1 | $57.3M | Sell |
544,835
-3,880
| -0.7% | -$408K | 30.98% | 1 |
|
|
2021
Q4 | $59.1M | Buy |
548,715
+7,820
| +1% | +$843K | 25.86% | 1 |
|
|
2021
Q3 | $59.3M | Sell |
540,895
-5,880
| -1% | -$644K | 23.52% | 2 |
|
|
2021
Q2 | $51.2M | Hold |
546,775
| – | – | 21.19% | 2 |
|
|
2021
Q1 | $50.3M | Buy |
546,775
+109,800
| +25% | +$10.1M | 22.36% | 2 |
|
|
2020
Q4 | $32M | Buy |
436,975
+9,510
| +2% | +$696K | 13.02% | 3 |
|
|
2020
Q3 | $33.2M | Buy |
427,465
+111,140
| +35% | +$8.63M | 18.04% | 2 |
|
|
2020
Q2 | $17.6M | Buy |
+316,325
| New | +$17.6M | 9.5% | 2 |
|